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Abstract  
Auditory hallucinations are prevalent in many neuropsychiatric disorders and are also a cardinal 
symptom of schizophrenia. Most research on the mechanism of auditory hallucinations has 
focused on functional imaging of the auditory cortex. Recent research has revealed structural 
and functional interaction between the striatum and the neocortex. Previous studies in our 
laboratory have shown that dopamine infusion into the posterior caudatoputamen (CPu), the 
“auditory striatum,” produce activation of the rat auditory cortex. To establish the next projection 
site from these neurons, we virally infused an anterograde AAV-GFP into this region of the 
auditory striatum which resulted in expression mainly at the same rostral-caudal level of the 
lateral globus pallidus (LGP) as the infusion site. Since antipsychotic drugs target D2 dopamine 
receptors on neurons of the indirect pathway (CPu-LGP) to alleviate psychotic symptoms, we 
transfected terminals in the LGP with a retrograde AAV-Jaws-GFP to neuroanatomically 
discriminate the indirect pathway. Inactivation of the striatal indirect pathway neurons with Jaws 
stimulation resulted in significant activation of the auditory cortex via c-Fos expression. 
Conversely, activation of these same striatal indirect pathway neurons with stimulation of 
ChannelRhodopsin-2 (ChR2) showed no significant change in auditory cortex activation. The 
results of these studies will elucidate a potential alternative neural circuit mechanism underlying 
the pathophysiology of auditory hallucinations in neuropsychiatric disorders. 
 
 
 
 
 
 
 
 
 
 
 
 
 
9 
 
CHAPTER 1 
BACKGROUND LITERATURE 
1.1 Schizophrenia and symptomology 
Schizophrenia is a heterogeneous neuropsychiatric disorder that affects nearly 1% of the 
global population (Javitt & Sweet, 2015). The exact etiology of this disease is currently under 
debate; however, there exists quite a few genes and environmental risk factors that imply its 
underlying pathogenesis. It is often characterized by the presence of its cardinal positive 
symptoms- delusions and hallucinations. But sufferers from this disorder can also present with 
negative and cognitive symptoms. Some examples of negative symptoms include flat affect, 
anhedonia, social withdrawal and apathy. The cognitive symptoms present themselves as a 
reduction of cognitive abilities as sufferers of this disorder have been shown to have reduced IQ 
scores compared to the average (100 IQ) (Javitt & Sweet, 2015).  
 
1.1.1 Prepulse inhibition as a biomarker for schizophrenia 
Individuals suffering from schizophrenia have been shown to have deficits in 
sensorimotor gating (Mena et al., 2016). Sensorimotor gating is the ability to screen (filter) out 
irrelevant stimuli to grant an uninterrupted or smooth processing of more immediate sensory 
matters. This means that healthy individuals who have this ability are capable of habituating to 
repetitive stimuli or predictive stimuli. This deficit in sensorimotor gating has become a popular 
biomarker for those suffering from schizophrenia. Prepulse inhibition (PPI) has become a useful 
diagnostic test for schizophrenia as it has been shown to be present in the acute and chronic 
phase of the disease (Mena et al., 2016).  
 
1.2 Pharmacological models of positive symptoms 
Positive symptoms of schizophrenia can be characterized uniquely by at least three 
pharmacological models. The models are as follows: Overactivation of Dopamine D2 receptor 
with psychostimulants, activation of serotonin 5HT2A receptors with psychedelics (LSD) and 
inactivation of glutamate NMDA receptors with dissociative anesthetics (i.e. phencyclidine) 
(Rolland et al., 2014). These models essentially depict the effectiveness of a particular 
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neurotransmitter/substance and its interaction with its associated receptor to induce 
hallucinatory or delusory symptoms. 
 
1.2.1 Perspective of Serotonin 
The ability of lysergic acid diethylamide (LSD) and other psychedelics to induce 
psychotic symptoms (i.e. vivid visual hallucinations) and its mechanism of action on serotonin 
receptors has implicated serotonin’s involvement in explaining symptoms of schizophrenia. 
Psychedelic research has correlated the binding of 5HT2A receptors agonists and the ability to 
produce LSD like hallucinatory symptoms (González-Maeso & Sealfon, 2009). Transgenic mice 
studies have further shown the necessity of regional 5HT2A receptors in mediating a 
hallucinatory response. Where it was shown that cortical expression of 5HT2A receptors in mice 
was necessary for induction of positive symptoms (González-Maeso et al., 2007). The 
abnormality in 5HT2A receptors seen in patients with schizophrenia and also the effectiveness 
of 5HT2A antagonism with antipsychotics further establishes the importance of this receptor in 
explaining a mechanism of hallucinations (Vollenweider & Geyer, 2001). 
 
1.2.2 Perspective of Glutamate 
Dissociative anesthetics like phencyclidine (PCP) have been observed to induce a 
variety of schizophrenia-like symptoms (Rolland et al., 2014). PCP was shown to induce its 
psychotomimetic effects through the binding of glutamatergic NMDA receptors (Javitt & Zukin, 
1991). This effect is mediated via PCP’s noncompetitive inhibition of NMDA receptors. Other 
dissociative anesthetics such as ketamine are also shown to antagonize NMDA receptors (Javitt 
& Zukin, 1991). Because of these discoveries involving altered glutamatergic transmission and 
psychotic symptoms, researchers have been interested in the therapeutic role from stimulation 
of this category of receptors. Antipsychotic potential has been shown in selective agonism of 
metabotropic glutamate receptor (mGlu2/3) in patients suffering from schizophrenia (Patil et al, 
2007). These findings alone strongly support a role of glutamate neurotransmission in the 
explanation the multifactorial symptomology of schizophrenia. 
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1.2.3 Perspective of Dopamine 
The role of dopamine in psychosis became evident from studies which illustrated the 
ability of amphetamines, a class of drugs known to increase monoamines (i.e. Dopamine) at the 
synapse, to induce psychotic symptoms. However, the conclusive finding was in how effective 
antipsychotic medications (i.e. Haloperidol, dopamine D2 receptor antagonist) were in treating 
positive symptoms of psychosis (Seeman, 2013). Additionally, studies began to correlate 
increase D2 receptor presence in cases of schizophrenia where individuals suffer from 
hypersensitivity to drugs that increase dopamine neurotransmission (Seeman, 2013). Even 
though positive symptoms of schizophrenia can be explained by several pharmacological 
models, it is believed that they contribute uniquely to a specified phenomenological aspect of a 
psychotic symptom (type of hallucinatory experience) (Rolland et al., 2014). For instance, the 
positive symptoms resulting from agonizing 5HT2A receptors tend to be more visual than 
antagonism of D2 receptors which tends to be more auditory based. The same can be said 
about the involvement of the glutamatergic system when explaining the phenomenology of 
positive symptoms. Prior studies done within our lab have shown that graded dopamine infusion 
within the striatum were able to induce auditory cortical activation in rats (Parga et al., 2019). 
These results have convinced us of a specific role that the dopaminergic system has on 
explaining auditory hallucinations. 
 
1.2.4 Dopamine hypothesis 
The dopamine hypothesis has been a longstanding, prominent and highly revisited 
theory for understanding psychotic symptoms. In Howes’ and Kapur’s review on the dopamine 
hypothesis, they emphasize the various versions of its neurochemical description and its 
evolution through time. With later neuroimaging studies and the effectiveness of antipsychotics, 
relying on high affinity for Dopamine D2 receptors, a revised version the dopamine hypothesis 
was incarnated with specifications to subcortical structures and specific dopamine receptors 
(Howes & Kapur, 2009). The various distribution of Dopamine receptors in the brain, D2 
receptors being primarily subcortical, further emphasized the subcortical specificity of 
dopamine’s involvement with psychotic symptoms. Lesions in the prefrontal dopamine neurons 
led to an increase in subcortical, striatal, dopamine levels which ultimately introduced an 
additional hypodopaminergic prefrontal cortex model (Pycock, Kerwin, & Carter, 1980). 
Prefrontal hypo-dopaminergic state was later hypothesized to be directly involved with the 
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negative symptoms of schizophrenia. The revised dopamine hypothesis has now begun to 
specify regional dopamine abnormalities with symptoms of psychosis. Unfortunately, the exact 
mechanisms by which dopamine was to inflict the specific symptoms of psychosis still remained 
undiscovered. As charming as the hypothesis made dopamine’s role in psychosis to be, the 
etiological role in schizophrenia was elusive.  
 
1.3 Hallucination research 
A hallucination is regarded as a perceptual experience that occurs in the absence of 
external stimuli and must be compelling enough to be mistaken as a sensual experience (Allen 
et al., 2008). Taking this broader definition of auditory hallucinations into account, we subject 
ourselves to encapsulating a continuum of various auditory percepts that are often times only 
distinguished in the clinical setting or clinical research. However, considering that our level of 
inquiry for studying hallucinations lies on the systems/physiological level, this should be 
sufficient.  
Although the vast majority of individuals diagnosed with schizophrenia seek clinical help due to 
their experience with the positive symptoms of psychosis, it is not unique to schizophrenia. Of 
the general population, 8% experience hallucinations and half of this population consider the 
overall experience distressing (Howes & Kapur, 2009). Because of the majority of individuals 
that have reported experiencing hallucinations, whom have not been diagnosed as having 
psychosis, makes the matter of understanding the mechanisms of hallucinations more urgent.  
A very important phenomenological characteristic of auditory hallucinations is the perceived 
location. Auditory hallucinations are sometimes reported as originating from inside the head (i.e. 
internal auditory hallucinations) or from outside the head (i.e. external auditory hallucinations) 
(Blom, 2015). They can also be experienced on one side or rather both sides, giving rise to 
unilateral and bilateral hallucinations respectively. Even more strangely, some auditory percepts 
are reported from various parts of the body, such as various limbs or torso etc. These oddly 
located percepts have been termed extracampine hallucinations (Blom, 2015). Another critical 
finding pertaining to these phenomenological features of auditory hallucinations is how they tend 
to vary from one psychiatric disorder to another (Blom, 2015). These characteristics are very 
important as they themselves allude to the processing aspect of audition that has gone awry. 
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Traditional approaches to studying hallucinations have focused on the structural and functional 
neuroimaging studies. [18F]Fluoro-deoxyglucose positron emission tomography (FDG-PET) has 
been used to observe real-time changes in cortical metabolic activity of patients with 
schizophrenia experiencing auditory verbal hallucinations (AVH). FDG-PET has allowed for 
researchers to pin-point areas such as the left frontal-temporal cortex and caudate nucleus as 
being hyperactive during AVHs (Horga et al., 2011). Studies utilizing arterial spin labeling, non-
invasive perfusion imaging technique to monitor cerebral blood flow (CBF), have correlated 
increased CBF within superior temporal gyrus (auditory cortex) and dorsal striatal regions in 
schizophrenic patients experiencing auditory hallucinations (Zhuo et al., 2016). Functional 
magnetic resonance imaging with BOLD-contrast (Blood-oxygen-level-dependent imaging) is 
another powerful neuroimaging technique for brain activity which relies on the difference in 
magnetic properties of deoxygenated and oxygenated hemoglobin. Studies engaging fMRI-
BOLD-contrast have been fundamental for detecting active cortical and subcortical elements 
during AVHs (Shergill et al., 2000). In the review paper on neuroimaging studies, patients with 
schizophrenia experiencing auditory verbal hallucinations tended to have decreased volumes of 
temporal lobe adjacent to the left insula, compared to those who are not experiencing AVHs 
(Bohlken, Hugdahl & Sommer, 2016). Another study found that the severity of AVHs is related 
to the decrease in volume of Heschl’s gyrus or the primary auditory cortex (Levitan, Ward & 
Catts, 1999). However, other studies have reported increased grey and white matter volumes in 
their patients who experience hallucinations compared to non-hallucinating ones (Shin et al., 
2005). Though authors of this study surmised that this result is likely due to the unmedicated 
state of the subjects in the study (Shin et al., 2005). To conclude, there is much speculation on 
the matter of explaining hallucinations in people who experience them, and the 
mechanism/neuro-circuitry of hallucinations remains to be discovered.  
 
 
1.3.1 Rodent model of hallucinations 
From the distinction in neuroanatomy alone, it is difficult to entrust rodent models with 
translatable data for future clinical discoveries. For example, pertaining to the basal nuclei in 
humans, there is a distinct separation between the caudate nucleus and the putamen by the 
fibrous tracts of the internal capsule. However, in rodents the caudate and putamen are not 
demarcated but combine into a similar but homogenous structure known as the 
caudatoputamen. Even though this structure appears to be homologous due to it being an 
undivided structure, it was found to be heterogeneous in its afferent connections with the 
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neocortex (Veening, Cornelissen, & Lieven, 1980). The HRP labeling study of the rodent 
caudatoputamen done by Veening, Cornelissen and Lieven was one of the first instances to 
show a topographical organization of cortical inputs at the level of the striatum and also the first 
to suggest a complex integratory function of several brain regions at the striatum. Even though 
rodent models are crucial for the discoveries in basic medical research, can we still assume that 
they are a reliable model for studying complex experiences such as auditory hallucinations?  
In Canetta’s and Kellendok’s article, “Can We Use Mice to Study Schizophrenia”, they discuss 
the importance of refining the animal model in characterizing the symptoms of schizophrenia 
and other psychiatric disorder (Canetta & Kallendonk, 2018). Positive symptoms have been 
notoriously difficult to model. The most commonly approached mechanism for positive 
symptoms of schizophrenia relates to the dopamine hypothesis and D2 receptor hyperactivity in 
the striatum. This is supported by studies which have shown that enhanced occupancy of D2 
receptors by dopamine in the striatum is characteristic in drug naïve patients with schizophrenia; 
as well as enhanced striatal dopamine and the correlation with severity of positive symptoms 
(Canetta & Kallendonk, 2018).  
However, schizophrenia’s positive symptoms effect individuals specifically and are often times 
characteristic of the patient. This is why it is crucial to emphasize specific circuity-based 
approach to delineate the experience of positive symptoms. The overexpression of D2 receptors 
in the striatum of mice have shown to impair spatial working memory and associative learning, 
these of which are tasks traditionally associated with medial prefrontal cortex function (Canetta 
& Kallendonk, 2018). An example from our research is elucidating the function of the posterior 
striatum in rodents regarding auditory cortex activation. This finding is important as it suggests a 
potential pathway that might be involved with internally generated auditory experiences or 
perceptions of sound. Which we believe is crucial towards developing more sophisticated 
animal models of auditory hallucinations, as well as furthering our understanding of 
hallucinations in general.  
 
1.4 Basal ganglia and posterior striatum 
The basal ganglia are a group of subcortical nuclei that are largely responsible for motor 
and sensory decisions, or also neatly summarized as psychomotor behavior and 
procedural/associative learning (Ring, 2002). The striatum is a region of the basal ganglia that 
receives the majority of cortical inputs (Ring, 2002). This region has generally been demarcated 
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into ventral striatum, which contains the nucleus accumbens and the olfactory tubercle, and the 
dorsal striatum which includes the caudate nucleus and putamen. However, recent findings 
suggest that a functional segregation of the striatum is important for understanding the function 
of this structure (Hunnicutt., Jongbloets. et. all, 2016). When a functional demarcation of the 
striatum is considered, we now have the four domains, sensorimotor, limbic, associative and a 
fourth posterior domain. The posterior striatum has been shown to be involved with auditory and 
visual processing. However, the precise demarcations of these functional subdivisions are 
relatively new and only recently have studies tried to thoroughly study these boundaries 
(Hunnicutt., Jongbloets. et. all, 2016). This approach to elucidating the striatum is important as 
the consideration of the striatum for auditory hallucinations has largely gone unnoticed (Figure 
1).   
 
 
 
Figure 1. Simplified illustration of Cortico-Striatal-Pallidal-Thalamo-Cortical loops in sagittal 
illustration of rat brain. Inspired by Parkinson’s disease motor studies and sensory studies 
showing auditory cortex projections in striatum (Wichmann & Dostrovsky, 2011) (Chen et al., 
2019). 
A region of the posterior striatum- tail of the caudate, is known to participate in visual processing 
(Seger, 2013). Seger discusses in this review the difficulty of studying this neuroanatomical 
structure due to a lack of sensitivity in measuring the activity of this region with neuroimaging 
techniques and a poor non-human animal model. To emphasize his point, the tail of the caudate 
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nucleus is often times overlooked. Even though this structure has recently been shown to have 
an important role for both visual and auditory processes.  
A recent study by Liang Chen and Xingxing Wang looked into the aspects of this posterior 
region of the striatum for auditory processing and have found afferent connections from both 
auditory cortex and auditory sensory thalamus (medial geniculate body of thalamus) (Chen et 
al., 2019). They used chemogenetics to silence these connections to show their involvement 
with auditory frequency discrimination in mice. They concluded that the MGB medium spiny 
neurons functions mainly as a gain controller- discriminating frequencies at a broad range and 
the auditory cortex medium spiny neurons provide tuning information of sounds (Chen et al., 
2019). This is a crucial finding as it further clarifies the role of auditory processing in the fourth 
functional subdivision of the striatum- tail of the striatum. Additionally, much earlier studies of 
auditory cortices involvement in the basal ganglia, have shown that picrotoxin (noncompetitive 
GABA-A receptor antagonist) infusions into the auditory cortex results in ipsilateral expression 
of c-fos in the caudal striatum (Arnauld et al, 1996). These results validate a theory of a 
posterior region of the striatum that is involved with auditory processing. However, to the best of 
our knowledge no such studies have been able to establish the full cortico-striato-pallido-
thalamo-cortical loop at the topographical level of the auditory cortex (Figure 1).  
The posterior striatum has a stable representation of sounds which implies an importance for 
auditory decisions (Guo, Walker, et al., 2018). Their results showed that activation of the 
posterior striatum had no effect on motor initiation; instead it was shown that this region is 
involved with auditory decisions. They were able to show through bilateral injections of 
muscimol (GABA-A Receptor agonist) into the posterior striatum resulted in an impairment of 
auditory decisions as compared to saline control (Guo et al., 2018). These results support the 
need for our study to confirm the striatal-pallidal-cortical within in the posterior striatum.  
 
1.5 Optogenetics and neuronal excitation 
Optogenetics provides a temporally and spatially effective way of activating or 
inactivating neurons. Optogenetics grants the ability to be able to specifically turn on or off 
neurons that have been transfected with optically active ion channels. This technique has 
allowed researchers to correlate circuit level neuron activity in vivo to study animal behavior 
(Britt, McDevitt, and Bonci, 2012). In our experiment we will be utilizing Channelrhodopsin-2 and 
Jaws to manipulate neurons posterior striatum within the indirect pathway.  
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Channelrhodopsin-2 (ChR2) is found within the algae Chlamydomonas reinhardtii. These 7 
transmembrane domain protein channels provided algae with the perception of light (Lin, 2011). 
ChR2 is a non-selective cation channel which is capable of depolarizing neurons once activated 
by light (Britt, McDevitt, and Bonci, 2012). The appropriate wavelength of light for achieving a 
sufficient response from ChR2 is 473nm blue light. In previous studies done in our lab, we have 
found that 10hz stimulation with 473nm light was sufficient enough to elicit a c-Fos response in 
cells directly affected by channelrhodopsin-2. 
Stimulation of ChR2 at 10Hz was shown to be effective in activating neuronal activity in a variety 
of studies. Striatal glutamatergic activation, in transgenic mice expressing ChR2, with 473 nm 
blue light at 10Hz resulted in Ca2+ influx and increased membrane currents (Song et al., 2017). 
In the same study, it was shown that laser power ranging from 0.35 to 1.02 mW was sufficient to 
achieve the desired neuronal activity. Another study focused on the use of ChR2 transgenic 
mice in exploring olfactory processing, was able to show that neuronal spike generation is very 
reliable for stimulation frequencies ranging from 10 to 40 Hz (Arenkiel et al., 2007). The 
frequency parameter of 10Hz is therefore a highly reliable way of activating neurons with the 
ChR2 actuator.  
Silencing neurons with the use of optogenetically active chloride ion and proton pumps has also 
been a powerful technique for causally assessing neuronal circuit function. However, the ability 
to silence larger quantities of tissue became difficult due to the penetrability of light used to 
activate these opsins. The Red-shifted Cruxhalorhodopsin, Jaws, was discovered from the 
shark strain of Haloarcula salinarum. After some additional modifications were made to improve 
light induced photocurrents and its expression in neurons; It was found to be a powerful addition 
to the toolset of inhibitor type opsins (Chuong et al., 2014). Compared to previous optogenetic 
inhibitors, Jaws was found to produce higher light induced currents upon red light stimulation. 
Jaws is capable of mediating these inhibitory photoinduced currents through changes in chloride 
ion conductance (Chuong et al., 2014). The penetrability of 632 nm red light allows Jaws to be 
activated in sparser/deeper regions of the brain and has even been shown to be activated from 
a transcranial red-light source. This is likely due to longer wavelengths of light having less 
interaction with blood proteins and lipids (Chuong et al., 2014). 
Inhibitor opsins work best at the lower frequency stimulation parameters. This is due to the 
effect of having a post-illumination rebound. Jaws was shown to be activated with 1s pulses at 
0.1 Hz with various light intensities (10, 25, 50, 75 mW/mm2) (Chuong et al., 2014). The 
parameters we decided to test with our pulsatile receiver are 8s pulse at 0.1 Hz and 3s pulse at 
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0.3 Hz. Due to the prevention of overheating the battery on our pulsatile receiver, we deemed 
these near continuous parameters as sufficient for testing.  
There are several ways of incorporating optogenetic genes within the desired animal. Some of 
these are electroporation, transgenic animals or by transfection with virus. The viral method for 
delivery of optogenetic genes is very common due to its rapidity and relatively simple method of 
viral delivery. It is crucial to restrict expression of the opsin to certain neurons to achieve 
experimental specificity (Britt, Mcdevitt, and Bonci, 2012). Researchers can utilize a cre/lox 
system to mediate viral expression of optogenetic genes. This is done by utilizing transgenic 
cre-expressing mice to limit the ability of viruses to express opsin genes only in the presence of 
cre recombinase. The cre recombinase is able to perform recombination at specific sites in the 
viral DNA allowing for opsin expression (Britt, Mcdevitt, and Bonci, 2012). This results in only 
neurons with sufficient levels of cre recombinase to have opsin expression.  
 
1.5.1 Wireless optogenetics 
  Wireless optogenetics offers an unimpeded optogenetic approach while actively 
observing animal behavior. Utilizing the Amuza’s Teleopto wireless optogenetic system for our 
studies, we will be implementing light emitting diodes (LED) source with implantable fiber optics. 
There are two choices of a light source for optogenetics that include diode-pumped solid-state 
lasers (DPSS) and light emitting diodes (LEDS). Lasers and LEDs are both characterized by 
their wavelength and light intensity. However, LEDs have the advantage of being less 
expensive. LEDs are also supplied in a wide variety of wavelengths and are smaller which 
allows for a more mobile approach to tissue stimulation. However, when compared to lasers 
LEDs can suffer on the intensity of light delivered. This was seen as a problem as sufficient light 
intensity is required to provide activation while also concerned with minimization of tissue heat 
(Britt, Mcdevitt, and Bonci, 2012). However, these issues were considered in preliminary studies 
done in our lab with LED wireless optogenetics. We have not had any observable issues with 
tissue heat while running our stimulation parameters at the predicted light outputs (5-10mW 
range). 
1.5.2 c-Fos as an indirect marker of neuronal activity 
Since it was identified as a proto-oncogene (Curran et al, 1984), the immediate early 
gene (IEG) c-Fos and its associated Fos protein has long been used as an indirect marker of 
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neuronal activity. The family of Fos proteins, which include c-Fos, FosB, Fos-related antigen 1 
and Fos-related antigen 2, are categorized as nuclear oncogenes. The expression of Fos 
protein is relatively rapid and is induced by a variety of extracellular factors (Chung, 2015). 
Once translated, the Fos protein will dimerize with an associated Jun protein to form Activator 
Protein-1 which acts a transcription factor. In the event of neuronal depolarization, intracellular 
calcium signaling occurs mainly from L-type voltage-sensitive calcium (VSCC) and glutamate 
receptors (NMDAR) (Chung, 2015). These signaling events have been shown to induce c-Fos 
m-RNA and Fos protein expression. Because of the instability of c-Fos mRNA and auto-
repression of the mRNA from the Fos protein, there are very low constitutive levels of c-Fos. 
This low level of basal c-Fos expression makes it an ideal marker for neuronal activation.  
There are also some aspects of c-Fos expression that reduce its effectiveness as a marker for 
neuronal activity. The levels of c-Fos expression can vary substantially with repetitive 
stimulation (Chung, 2015). This is due to neural plastic changes that occur which can either 
sensitize or desensitize depending on the change. Although this phenomenon does make c-Fos 
a unique way to measure physiological changes that occur during learning.  
 
1.6 Research question 
The importance of functional subdivisions within the auditory striatum have recently 
begin to emerge with studies aiming towards a delineation of function regarding auditory cortical 
and sensory thalamic afferents terminating within this region (Chen et al., 2019). To the best of 
our knowledge, a complete cortico-striatal-pallidal-thalamo-cortical loop as suggested in Figure 
1, remains to be fully established for the auditory cortex. The discovery of such a model we 
believe has profound implications in the fields of psychiatry and others interested in modeling 
auditory hallucinations. We know from previous studies that hyperdopaminergic activity in the 
striatum is correlated with positive symptoms of schizophrenia and also presents a well-
established, common model for representing these states of mind (Canetta & Kallendonk, 
2018). We hypothesize that inactivation of striatal-pallidal neurons within the indirect pathway of 
the posterior striatum (caudatoputamen in rats) with stimulation of Jaws will produce an effect 
similar to enhanced dopamine D2 receptor activity and result in auditory cortex activation. We 
also hypothesize that activation of striatal-pallidal neurons within the same indirect pathway of 
the posterior striatum with ChannelRhodopsin-2 will produce an effect similar to impoverished 
dopamine D2 receptor activity and result in less auditory cortex activation. 
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CHAPTER 2 
DEFINING THE POSTERIOR STRIATAL/PALLIDAL PATHWAY IN RODENTS AND 
OPTIMIZATION OF OPTOGENETIC PARAMETERS FOR THE USE OF JAWS AND 
CHANNELRHODOPSIN-2 
2.1 Project Summary 
Background: The precise projection locations of the posterior striatal neurons in the rodent 
caudatoputamen to the lateral globus pallidus have not been fully ascertained in our lab. The 
stereotactic location of these striatal terminal projections in the lateral globus pallidus is crucial 
for our future experiments involving opsin expression in the posterior striatum. Utilizing the 
same coordinates previously used in our lab to achieve zif268 mRNA expression in the auditory 
cortex of rodents via graded dopamine infusions, we will label this connection from the posterior 
striatum to the pallidum via an anterograde adeno-associated virus expressing GFP (Parga et 
al., 2019). The terminals will be confirmed with fluorescent microscopy.  
The optogenetic parameters for stimulating and inhibiting the striatal-pallidal indirect pathway 
neurons needed to be confirmed for this region. Previous studies support a continuous set of 
stimulation parameters for activating Jaws (Chuong et al., 2014). However, our lab does not 
acquire the devices to simulate these continuous conditions for Jaws activation. However, we 
intend on utilize a pseudo-continuous set of parameters in this preliminary experiment to 
determine which one is more effective at activating the Primary (M1) and Secondary (M2) motor 
cortices. The parameters for stimulating the indirect pathway with channelrhodopsin were 
determined by previous experiments in our lab via successful stimulation of infralimbic cortex to 
ventral tegmental area projection neurons.  
Methods: The locations of the anterograde projections of AAV-hSyn-GFP (50465-AAV5, 
addgene) two weeks after unilateral infusion in the posterior caudatoputamen in rodents were 
analyzed. Retro viral expression of AAV-hSyn-Jaws-KGC-GFP-ER2 (#65014-AAVrg, addgene) 
requires 6 weeks for optimal expression. After the optimal expression period of the retrograde 
AAV-Jaws in rodents involved in the parameter study, they were surgically implanted with a 
unilateral fiber optic (630nm, 0.67 NA, 0.5mm Diameter, Teleopto). After a three-day postop the 
rats involved in the parameter study were habituated for several days until stimulation. The 
brains were then serially sectioned to span a millimeter of lateral globus pallidus tissue near 
respective infusion sites. The tissue was then imaged using the M2 Epifluorescent Axioskop 
microscope to assess GFP expression.  
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Optogenetic parameters: The set of parameters used for pseudo-continuous stimulations: 8 
second pulse at 0.1 Hz (Parameter A) with 630nm light for a 30-minute period; and 3 second 
pulse at 0.3 Hz (Parameter B) with 630nm light for a 30-minute period. 
Behavioral paradigm: On stimulation day rats were given a 20-minute habituation period after 
the wireless receiver was fitted, followed by the 30-minutes of optogenetic stimulation with the 
respective parameters, and then were perfused an hour following the stimulation to allow 
adequate c-Fos expression. 
Results: The images showed distinct expression in the lateral globus pallidus (LGP) following 
correct infusion of AAV-hSyn-GFP in the posterior caudatoputamen (-1.8mm A/P, +4.3mm M/L, 
-6.0mm D/V). The expression was lateral in the LGP, closest to the caudatoputamen. The 
approximated coordinates of maximum expression were ascertained to be around -1.8mm A/P, 
+3.9mm M/L and -6.0mm D/V.  
There was no observed difference in locomotion from the two pseudo-continuous optogenetic 
stimulation parameters. There was also no significant difference in c-Fos expression in motor 
cortices resulting from the different optogenetic parameters. 
Conclusion: The results of this tracing study have allowed for us to determine the stereotactic 
location of our target in the LGP for the infusion of retro-AAV-JAWS/ChR2-GFP. We have 
decided to utilize the 3s-ON and 100ms-OFF (Parameter B) pseudo-continuous parameters for 
Jaws. This parameter has less light-off time and appears to run well with the equipment. The 
parameters 10Hz 1-minute stimulation will be used for ChannelRhodopsin-2. These parameters 
have shown to be sufficient for studies requiring neuronal activation with the respective opsins.  
 
2.2 Experimental Design/Animals 
Subjects: The viral tracing study consisted of 12 Sprague Dawley rats received from 
Charles river laboratory. The operating weight was maintained at 250 grams, this would ensure 
the most accuracy when referencing the stereotactic coordinates from the Paxinos and Watson 
atlas. The optogenetics studies included 2 for pseudo-continuous parameter optimization and 1 
for the optimization of channelrhodopsin. These were Long Evans rats around 250 grams. All 
Animals were group-housed in a controlled environment with 12-hour reverse light/dark cycle 
housing. Food and water were available ad libitum. These experiments were all approved by the 
University of Arizona Institute of Animal Care and Use Committee.  
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2.3 Intracerebral viral infusion and Fiber Optic Implantation 
During stereotaxic surgery, 2-4% continuous supply of isoflurane gas was administered 
using a vaporizer and fume evacuator. Each subject was administered a 1mg/kg dose of 
meloxicam (Alloxate) for post-surgical analgesia. Unilateral craniotomies were performed and 1 
µl of AAV2-hSyn-eGFP (#50465-AAV2, addgene) at a titer of 3x1012vg/mL was unilaterally 
infused into the posterior caudatoputamen (-1.8 A/P, +4.5 M/L, -6.0 D/V, 0̊ tilt, from Paxinos and 
Watson, 2007). Approximately 2 weeks later, brains were collected for striatal projection 
analysis. Brains infused with 1 µl of AAV-hSyn-Jaws-KGC-GFP-ER2 (#65014-AAVrg, addgene) 
at a viral titer of 1.3x1013 GC/mL at coordinates (-0.8mm A/P, +2.9mm M/L, -6.0mm D/V, 00) 
were implanted with unilateral LED fiber optrodes (0.5mm diameter, 0.67 NA, 630nm, 10mW 
output, Teleopto, Nagoya, Japan) into the identified region of the rostral striatum. Output of LED 
fiber was deemed effective for Jaws stimulation by use of the “Predicted irradiance calculator” 
(Figure 2) from the optogenetics resources at Stanford University. This calculator was 
formulated from measurements of light penetrance in mammalian tissue and was used to 
determine our fiber optic output (10mW) for achieving an irradiance of roughly 0.1mW/mm2 at 
tissue depth of 2 mm. 
 
Figure 2: Predicted irradiance (mW/mm2) given numerical aperture of fiber (NA 0.67), power 
output (10 mW) and diameter of fiber (0.5mm) (“Predicted irradiance calculator”, Optogenetic 
Resources at Stanford University, 2019). 
2.4 Data and Tissue analysis 
2.4.1 Euthanasia and brain extraction 
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Animals were euthanized after receiving intraperitoneal injection with Euthasol sodium 
pentobarbital (200 mg/kg, i.p.) and transcardial perfusion with % paraformaldehyde (0.9% NaCl) 
for tissue fixation followed by decapitation by guillotine. These euthanasia methods are 
consistent with recommendations of the American Veterinary Medical Association Panel on 
Euthanasia. 
Once animals have received their i.p. injection with Euthasol they were anesthetized with 
isoflurane and were then transcardially infused with 15 mL of 1X PBS solution with Heparin. 
Following this infusion, animals were transcardially infused with approximately 250 mL of 4% 
Paraformaldehyde (0.9% NaCl). Animals brains were extracted and placed in a 4% 
Paraformaldehyde (0.9%) solution for 90 minutes. Following this period, brains were then 
placed in graded sucrose solutions (12.5% sucrose overnight, 25.0% sucrose until freezing). 
Freezing tissue involved coating the animal brain in O.C.T. (Optimal Cutting Tissue medium) 
and then snap freezing in crushed/powdered dry ice for roughly 60 seconds. These brains were 
then stored in a -800C freezer until sectioning 
2.4.2 Immunohistochemical analysis and imaging 
The CM195 Leica Cryostat was used to section frozen brain tissue which was then 
collected onto microscope slides. These slides were vacuum dried for 10 minutes and stored 
overnight in a 40C freezer prior to being stored in 80°C freezer until immunohistochemical 
procedures. The tissue infected with AAV2-hSyn-GFP (#50465-AAV2, addgene) were washed 
with 0.05M KPBS (pH=7.4) for 5 minutes prior to being coverslipped with ProLong™ Diamond 
Antifade Mountant (Invitrogen, P36970) to protect the slides for prolonged imaging. These slides 
were then imaged on the M2 Epifluorescent Axioskop microscope to visualize the expression in 
the lateral globus pallidus. 
The optogenetically stimulated animals were blocked with 5% Normal goat serum (0.05M 
KPBS, 0.4% Triton-X) for 1-hour prior to being stained with Phospho-c-Fos (Ser32) (D82C12) 
XP® Rabbit mAb (#5348, Cell signaling) antibody at 1:200 dilution for 48-hour period. The slides 
were then incubated with the Alexa Fluor-594 goat anti-rabbit IgG secondary antibody 
(Invitrogen, R37117) for a 45-minute period. Three 5-minutes washes in 0.05M KPBS (pH=7.4) 
were done in between antibody incubations. 
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2.4.3 Statistical analysis 
Motor cortices were analyzed at approximately (-0.8mm A/P). Three 20µm sections that 
resembled the aforementioned region were chosen for each animal and analyzed via automated 
cell counts with ImageJ Fiji software to produce a mean labeling profile of the given region. 
Parameters for the automated cell counts are 0.5-1.0 circularity, 30-255 image threshold and 
100-10000 pixel cell area. The total area used to count c-Fos expression was about 4.0mm2. 
Immunohistochemical data were analyzed via nonparametric statistical tests with unpaired t-test 
with Welch’s correction utilizing Prism statistical software. We determined statistical significance 
to be satisfied if the resulting p values ≤ 0.05.  
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2.5 Immunohistochemistry and Fluorescent imaging results 
2.5.1 Tracer study results 
Viral infusion into the posterior striatum (-1.8mm from bregma) resulted in lateral 
expression of green fluorescent terminals in the lateral globus pallidus (Figure 3). The most 
intensive labeling of GFP terminals were observed in the lateral globus pallidus at the same 
rostral-caudal level as the infusion site. Shown in Figure 4, terminal expression was also 
observed in the reticular thalamus (Rt), medial globus pallidus (MGP) and subthalamic nucleus 
(STh). However, we are only interested in the LGP projections, as these connections form the 
bulk of the indirect pathway. The location of these terminals can be approximated with the 
following stereotactic coordinates (-1.8mm A/P, +3.9mm M/L, -6.2mm D/V, 00). This location will 
be the target of our retrograde adeno-associated virus expressing its associated opsin (ChR2 or 
Jaws).  
 
Figure 3. Viral infusion of AAV2-hSyn-eGFP (#50465, addgene) into CPu (-1.8 A/P, +4.5 M/L, -
6.0 D/V, 0̊ tilt, from Paxinos and Watson, 2007). Neurons in CPu are marked with white arrows, 
dashed white line demarcates LGP from CPu. Scale bar at 1000 µm. 
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Figure 4. Viral infusion of AAV2-hSyn-eGFP (#50465, addgene) into CPu (-1.8 A/P, +4.5 M/L, -
6.0 D/V, 0̊ tilt, from Paxinos and Watson, 2007). Expression seen also in reticular thalamus (Rt), 
medial globus pallidus (MGP) and subthalamic nucleus (STh). 1000 µm scale bar.  
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2.5.2 Motor study Infusion site 
 
Figure 5. Red star indicates infusion site of retrograde AAV-hSyn-Jaws-KGC-GFP-ER2 
(#65014-AAVrg, addgene). Infusion coordinates (-0.8mm A/P, +2.9mm M/L, -6.0mm D/V, 00) 
Gaidica, M. (2019). Rat Brain Atlas. Retrieved 16 December 2019, from http://labs.gaidi.ca/rat-
brain-atlas/.  
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Figure 6. Expression of GFP from viral infusion of retrograde AAV-hSyn-Jaws-KGC-GFP-ER2 at 
stereotactic coordinates (-0.8mm A/P, +2.9mm M/L, -6.0mm D/V, 00). Arrow indicates c-Fos 
expression. Star indicates striatal neuron expressing GFP in CPu. Scale bar 1000µm. 
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Figure 7. Green Fluorescent Protein expression in motor cortices from infusion of retrograde 
AAV-hSyn-Jaws-KGC-GFP-ER2 at stereotactic coordinates (-1.0mm A/P, +2.9mm M/L, -6.0mm 
D/V, 00). Scale bar 1000µm. 
 
Infusion of the retrograde AAV-hSyn-Jaws-KGC-GFP-ER2 into a rostral potion of the striatum 
(Figure 5) known to be more influenced with motor activities resulted in expression lateral CPu 
(Figure 6) and ipsilateral cortical expression (Figure 7). Cortical expression shown in Figure 7 
illustrates the primary motor cortex connections with the LGP at this rostral/caudal level (-0.8 
A/P). There was little to no expression of c-Fos in the LGP and adjacent CPu. However, c-Fos 
can be detected in the medial thalamic regions shown in Figure 6.  
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2.5.3 Difference in c-Fos expression between optogenetic parameters 
 
Figure 8. Expression of c-Fos in primary (M1) and secondary (M2) motor cortices of rat. Red 
box illustrates the approximate region of stereotactic image where images on the right were 
taken. Parameter A) denotes the c-Fos expression resulting from 8s light pulse at 0.1Hz. 
Parameter B) denotes the c-Fos expression resulting from 3s light pulse at 0.3Hz. Scale bar 
500µm. Graph depicts c-Fos cell counts. 
 
 
 
 
 
31 
 
 Virus Stimulation 
Cell 
count 
(c-Fos) 
s1 s2 s3 
Mean cell 
count 
Unpaired 
t-test 
Welch’s 
correction 
F test 
comparison of 
variances 
Motor 
R2 Jaws 
8s pulse 0.1 Hz 
(parameter A) 199 122 198 173 
P-value 
=0.1314 
P-value=0.7955 
Motor 
R3 Jaws 
3s pulse 0.3 Hz 
(Parameter B) 313 216 222 250.33333 
Result = 
ns 
Result = ns 
Table 1. Illustrates the c-Fos cell counts for both parameters and the statistical analysis 
summaries. Area of analysis is roughly 4 mm2. 
The expression of c-Fos in motor cortices was more prominent after stimulation of Jaws with 
parameter B (3s pulse at 0.3Hz). However, the amount of c-Fos expressed from comparison of 
both parameters showed no significant differences (Table 1). 
 
2.6 Discussion 
The results of the tracing study have specified the stereotactic coordinates that will be 
utilized in a future study involving the expression of optically sensitive ion channels (opsins) in the 
indirect pathway of the posterior caudatoputamen. This experiment was necessary as we were 
uncertain of the specific rostral-caudal region of the lateral globus pallidus (LGP) which was being 
projected to from the posterior region of the caudatoputamen (auditory striatum). The region with 
the most terminal expression was found to be in the same rostral-caudal axis as the infusion site 
into the posterior caudatoputamen. We determined the coordinates for our retrograde adeno-
associated virus in experiment 2 to be (-1.8 A/P, +3.9 M/L, -6.0 D/V, 0̊ tilt, from Paxinos and 
Watson, 2007) in the LGP. 
We know from studies by Boyden’s lab that continuous parameters for stimulation of Jaws are 
optimal (Chuong et al., 2014). However, we do not possess a wireless receiver capable of running 
continuous parameters without damaging the equipment. Instead, we decided to test two pseudo-
continuous parameters, in the motor striatum, to ascertain which would be better at activating the 
motor cortex. Inactivation of the indirect pathway in the motor striatum (-0.8mm A/P, +2.9mm M/L, 
-6.0mm D/V, 00), was theorized to activate the motor cortex and possibly produce contralateral 
movement in the rats. The results of the optimization of optogenetic parameters showed no 
significant difference in c-Fos expression between Parameter A (8s pulse, 0.1Hz) and Parameter 
B (3s pulse, 0.3Hz). The mean number of cells expressing c-Fos (250 cells/4mm2.) was larger in 
parameter B. We have decided to utilize Parameter B due to it appearing to have more of a c-Fos 
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response. We believe this is likely due to Parameter B resembling a more continuous light source, 
when compared to Parameter A. Therefore, we will be using the 3s pulses at 0.3Hz parameter in 
our next experiment for stimulating Jaws in striatal neurons of the indirect pathway. 
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CHAPTER 3 
OPTOGENETIC MANIPULATION OF THE INDIRECT STRIATAL PATHWAY TO AUDITORY 
CORTEX 
3.1 Project summary 
 
Background: The auditory striatum has recently begun to emerge as a prominent striatal 
pathway for regulating elements of auditory information. Earlier studies done within our lab have 
shown that a posterior region in the caudatoputamen of rats, when infused with dopamine, is 
capable of activating the primary auditory cortex. This region of the caudatoputamen can be 
described as being analogous to an auditory striatal region. However, the precise locations of 
these auditory striatal projections have just recently been established through viral tracing 
studies done within our lab to terminate mainly in the adjacent lateral globus pallidus. We intend 
to utilize optogenetics to test whether this striatal-pallidum microcircuit is capable of activating 
the auditory cortex.  
Hypothesis: Stimulation of Jaws/inactivation of indirect striatal neurons will produce an effect 
analogous to enhanced dopamine activity on D2 receptors and will result in increased c-Fos 
expression within the auditory cortex. 
Methods: We have infused a retrograde AAV-Jaws/ChR2/GFP to express Jaws in 15 of our 
rats, Channelrhodopsin-2 (ChR2) in 6 of our rats, and GFP-only in 11 of our rats. After the 
optimal 6-week period of viral expression, the animals were surgically cannulated with fiber 
optics that permitted 630 nm light for AAV-Jaws and GFP-only groups and 470 nm light for 
AAV-ChR2 group. To ensure the rats did not dislodge the wireless optogenetic receiver during 
stimulation days, they were habituated with a dummy receiver for several days prior to days of 
stimulation. When stimulation day came, the rats were placed into a sound attenuated chamber 
and perfused 90 minutes afterwards to ensure optimal c-Fos expression from the optogenetic 
stimulation. The brains were extracted and immunohistochemically processed for c-Fos 
expression. These tissues were then imaged using fluorescent microscopy.  
Results: Immunohistochemical analysis of the tissue for c-Fos expression showed significantly 
higher levels of c-Fos after stimulation of Jaws in indirect striatal neurons when compared to 
GFP-only and ChR2 groups. Animals transfected with ChR2 showed significantly less c-Fos 
expression when compared to Jaws but not GFP. Ipsilateral auditory cortex (Au1) with respect 
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to the viral infusion/fiber-optic placement showed significantly higher levels of c-Fos expression 
only in animals transfected with AAV-Jaws.  
Conclusion: The results of this experiment suggests that the posterior caudatoputamen to lateral 
globus pallidus pathway is involved with auditory processes. Inhibiting this pathway with 
stimulation of Jaws was shown to significantly activate the primary auditory cortex when 
compared to the GFP control group. This supports our hypothesis that stimulation of Jaws within 
striatal neurons of the indirect pathway, analogous to dopamine inhibition via D2 dopamine 
receptor activation, results in increased auditory cortex activity. In addition, we also confirmed 
the contrasting effect through the activation of striatal neurons within the indirect pathway via 
stimulation of ChR2 and observed no significant change in activity of the auditory cortex. We 
also observed significant ipsilateral activation of the Fiber-optic side of the auditory cortex when 
compared to the contralateral auditory cortex in the Jaws group. These findings bring our 
research closer to specifying a pathophysiological mechanism for auditory hallucinations.  
 
3.2 Introduction 
The basal ganglia comprise a group of subcortical nuclei that indirectly modulate various 
activities of the neocortex. The striatum is a subdivision of the basal ganglia that is the primary 
recipient of cortical input. The striatum can be divided into ventral and dorsal divisions; the 
dorsal division is comprised of the caudate nucleus and the putamen. Neurons of the dorsal 
striatum can be characterized as either direct, expressing predominantly D1 dopamine 
receptors, or indirect, expressing D2 dopamine receptors. These receptor subtypes are 
characterized by the G-protein subunits they activate and the net effect they have on 
intracellular cAMP in response to their activation by dopamine. In this regard, D2 dopamine 
receptor neurons respond to dopamine by inhibiting adenylyl cyclase and decreasing 
intracellular cAMP, and conversely for D1 receptor response to dopamine. Thus, the D2 
dopamine receptor neurons of the indirect pathway are generally inhibited by dopamine, even in 
the presence of glutamate input, while direct pathway neurons respond to dopamine in a 
converse manner (Gerfen and Surmeier, 2010). 
Recent literature has focused on functional differentiation of the dorsal striatum. For example, 
the dorsal medial and dorsal lateral striatum have been functionally defined as executing goal-
mediated and habitual behaviors, respectively (Alloway, 2017). Furthermore, a subregion of the 
dorsal striatum is involved with auditory processing and receives inputs from the auditory cortex 
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and medial geniculate body of the thalamus (Chen et al., 2019). These auditory cortex 
projections may function to tune auditory information for striatal sound representations. In 
addition, the posterior striatum may act to modulate sensory processing and cognitive aspects 
of the neocortex. Our laboratory has shown that dopamine infusion into a caudal (posterior) 
region of the caudatoputamen activates the rat auditory cortex in a pattern similar to that 
produced by sound. We believe that this provides a reasonable model of striatal involvement in 
regulation of auditory cortical activity, as might occur in schizophrenia. In addition, caudate 
volume has been determined to be strongly correlated with antipsychotic treatment response in 
patients with schizophrenia (Hutchenson, 2014).  
An auditory hallucination is defined as the perception of a sound in a waking individual in the 
absence of an auditory stimulus (Blom, 2015). In the field of auditory hallucination research, 
there are many demarcations of the term to describe characteristics of the experience, e.g. 
auditory verbal/non-verbal hallucinations (Blom, 2015). Auditory hallucinations have been 
associated with a plethora of psychopathological states, including Parkinson’s disease, major 
depression, and PTSD, and are a cardinal symptom of schizophrenia (Mørch-Johnsen, 2016; 
Baumeister et al., 2017; Frei & Truong, 2017). The association of the dorsal striatum with 
auditory hallucinations remains largely unexplored. The hallucinatory experience has largely 
been understood through phenomenological and functional neuroimaging studies, which reveal 
auditory cortical activation during hallucination (Lennox et al., 2000). However, the literature 
shows little agreement on the pathophysiology of hallucinations, and to our knowledge, none 
has addressed the relationship between auditory cortical activation and the striatal level. This 
study aims to elucidate a novel circuit that will establish a relationship between the auditory 
striatum and auditory cortical activation. The results of this study would translate into novel 
approaches to understand one of the core symptoms of psychosis. 
 
3.3 Experimental Design 
We utilized rAAV-induced gene transfer following infusion into the target region of LGP 
as identified in earlier experiments to retrogradely label indirect pathway neurons, respectively, 
with ChR2, Jaws or no opsin (GFP only). Expression of these viral constructs provided 
retrograde expression of opsins to either excite or inhibit labeled indirect striatal neurons. These 
opsins are sensitive to different wavelengths of light illumination from the fiber optic; ChR2 is 
sensitive to 470 nm blue light, while Jaws is sensitive to 630 nm red light. Rats received 
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stereotaxic intracranial infusion (1.0 µL) of rAAV-GFP-Ch2R, rAAV-GFP-Jaws or rAAV-GFP into 
the LGP, then animals recovered for at least 6 weeks to allow for retrograde transport and viral 
expression of opsin proteins in striatal cell bodies. Following this 6 week period, rats received an 
additional surgery to implant a fiber optic into the target region of striatum (the region 
retrogradely labeled by the earlier AAV infusion). The fiber optic, containing an LED of the 
prescribed wavelength, was attached to the skull with embedded screws and dental cement. 
Following recovery of at least 3 days, animals were habituated to handling. A dummy receiver 
(same weight as the wireless receiver) was attached to the fiber optic atop the head, and the rat 
was allowed to habituate to the weight of the receiver prior to the day of stimulations. On the 
experimental day, the wireless optogenetic receiver was attached to the fiber optic atop the 
head, and the rat was then transferred to the sound attenuated chamber (Startle/PPI chamber) 
with 70 dB white noise for 20 min of acclimation, this background noise assures equivalent 
auditory stimulation in all cases, and intermittent pulsatile/pseudo-continuous optogenetic 
stimulation for 30 min. After 90 min from start of stimulation, the rat was removed from the 
sound attenuated chamber, anesthetized, euthanized and perfused with 0.9% saline and 4% 
paraformaldehyde, with the brain removed for processing. Immunohistochemical labeling for c-
Fos in serial sections through auditory cortex was imaged with fluorescent microscopy and 
analyzed with ImageJ Fiji automated cell counter. Labeling data was averaged from at least 
three adjacent sections to generate the mean labeling for that layer/region in that subject. 
 
3.3.1 Animals and Virus 
Subjects: This study consisted of 32 Sprague Dawley rats received from Charles river 
laboratory. These animals were separated in three cohorts: the first containing 6 animals 
transfected with 1.0 µL retro AAV-hSyn-GFP (#50465-AAVrg, addgene) with a viral titer of 
7×10¹² vg/mL and 6 transfected with 1.0 µL retro AAV-hSyn-Jaws-KGC-GFP-ER2 (#65014-
AAVrg, addgene) with a viral titer of 1.3x1013 GC/mL, the second cohort contained 3 rats 
transfected with 0.1 µL retro AAV-hSyn-GFP, 3 rats transfected with 1.0 µL AAV-hSyn-Jaws-
KGC-GFP-ER2 and 6 rats transfected with 1.0 µL retro AAV-Syn-ChR2(H134R)-GFP (#58880-
AAVrg, addgene) at viral titer of 7.4x1012 GC/mL and the third cohort contained 6 more in the 
retro AAV-hSyn-Jaws-KGC-GFP-ER2 group and two more in the retro AAV-hSyn-GFP group. 
The operating weight for viral infusions was maintained at 250 grams, this would ensure the 
most accuracy when referencing the stereotactic coordinates from the Paxinos and Watson 
atlas. After 6-week optimal retroviral expression of opsins/fusion proteins, rats weighed on 
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average 450 grams for initial fiber optic implant surgeries. Rats were also group-housed in a 
controlled environment with a 12-hour reverse light/dark cycle housing (lights on from 9PM-
9AM). Food and water were available ad libitum. These experiments were all approved by the 
University of Arizona Institute of Animal Care and Use Committee 
 
3.3.2 In vivo optogenetic stimulation setup 
Habituation periods started on the third day following fiber optic implant surgery. These 
days consisted of habituating the rats to a 2g Teleopto dummy receiver for 30 minutes up until 
the day of stimulation. On test day, a 2 g Teleopto wireless receiver was connected to the fiber 
optic atop the headmount. An IR remote emitter inside the sound attenuated chamber allowed 
for direct control of the receiver by TTL pulses from a programmable stimulator (located outside 
the chamber), providing ~10 mW of light output at the tip of the fiber optic. 70-dB white noise 
was constant throughout the period in the sound attenuated chamber. This background noise 
provided consistent sound throughout stimulation and also the attenuation of less controlled 
noises outside the stimulation room.   
 
3.3.3 Surgeries: Craniotomy and Fiberoptic implantation 
To prepare animals for surgical procedures, they were first anesthetized briefly in an 
isoflurane chamber. After brief anesthetization, the surgical site on the head was shaved and 
cleaned and the subjects were fitted to the Kopf stereotactic frame. The subjects were then 
fitted with a nasal piece that delivered continuous supply of 2-4% isoflurane. Each subject was 
administered a 1mg/kg dose of meloxicam (Alloxate) for post-surgical analgesia. Ipsilateral 
craniotomies were achieved with a drill which produced a 0.2 mm hole in the skull at the site of 
viral infusion, lateral globus pallidus (-1.8 mm AP, +3.9 mm ML, -6.0 mm DV), or fiber optic 
implantation, posterior caudatoputamen (-1.8 mm AP, +4.4mm ML, -4.8 mm DV). After viral 
infusions, the skull was cleaned, and the craniotomy was sealed with bone wax. Viral infusions 
were delivered with a 5µL Hamiltonian syringe. The incision site was closed with suture (Coated 
Vicryl 4-0 undyed braided suture, Ethicon) and lidocaine gel was applied followed by a triple 
antibiotic gel. For fiber optic surgeries, the fiber was placed in the 0.2 mm hole in the skull and 
sealed with acrylic cement (Ortho-Jet BCA powder, REF B1330, Lang Dental Manufacturing 
Co.). The headmount produced from the acrylic cement was fitted with two paperclips placed 
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orthogonal to each other. This allowed for a surface that was used to secure the Teleopto 
wireless optogenetic receiver to the headmount.  
 
3.3.4 Euthanasia of animals 
Animals were euthanized after receiving intraperitoneal injection with Euthasol sodium 
pentobarbital (200 mg/kg, i.p.) and by transcardial perfusion with 4% paraformaldehyde (0.9% 
NaCl) for tissue fixation in histochemical studies. These euthanasia methods are consistent with 
recommendations of the American Veterinary Medical Association Panel on Euthanasia. 
 
3.3.5 Tissue processing and Immunohistochemical analysis 
After extracted brains have settled for 90 minutes in 4% paraformaldehyde, brains were 
then treated with 12.5% (24 hours) and 25.0% sucrose gradients until tissue freezing. Brains 
were then immersed in O.C.T (optimal cutting tissue) medium followed by snap freezing in 
crushed/powered dry ice. These brains are then sectioned by the Leica CM195 Cryostat and 
collected on microscope slides which are vacuum dried for 10 minutes prior to being stored in 
4°C freezer overnight. Long term slide storage was kept in a -80°C freezer until 
immunohistochemical analysis is required.  
Immunohistochemistry processes involved staining for the transcription factor c-Fos. Slides 
were washed three times for 5 minutes in 0.05M KPBS buffer solution before and after each 
incubation period. Tissue was blocked with 5% Normal Goat Serum (NGS) solution made from 
0.05M KPBS (pH = 7.4) and 0.4% Triton X-100 for 1-hour. Afterwards, the tissue was incubated 
with the primary antibody, c-Fos Rabbit mAB (cell signaling, #2250), at 1:2400 dilution with 10% 
NGS (0.05 KPBS, 0.4% TX) for 48-hours. After this incubation period, the slides were then 
incubated with Alexa Fluor-594 goat anti-rabbit IgG secondary antibody (Invitrogen, R37117) for 
a period of 45-minutes. Once this incubation was complete, slides were then coverslipped with 
ProLong™ Diamond Antifade Mountant (Invitrogen, P36970). Immunofluorescence was 
captured using the Zeiss Axio Imager M2 upright widefield fluorescent microscope and the Zen 
image analysis software. ImageJ with Fiji was used to count cells labeled with c-Fos. Scale bars 
were converted from 2.25 µm/pixel for 5x images and 0.9 µm/pixel for 10x images.  
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3.3.6 Statistical analysis and mathematical equations 
Three 20µm sections from each animal within the same approximate region of the 
primary auditory cortex (-4.3 mm A/P) were analyzed with ImageJ Fiji via automated cell counts. 
The parameters used for the automated cell counts are 0.5-1.0 circularity, 30-255 threshold and 
100-10000 pixel cell area. The approximate size of the region for cellular analysis of the auditory 
cortex is 4mm2. Immunohistochemical data was analyzed via parametric statistical tests with 
one-way ANOVA, followed by Tukey’s multiple comparison test of optogenetic stimulation and 
two-way ANOVA followed by Sidak’s multiple comparison tests for ipsilateral/contralateral c-Fos 
expression in optogenetically stimulated brains. Statistical significance was determined if the 
resulting p values ≤ 0.05.  
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3.4 Results 
3.4.1 Infusion sites LGP-CPu microcircuit 
The results of our first experiment showed us that the lateral globus pallidus (LGP), at 
the same rostral-caudal level (-1.8 mm AP) as the infusion site in the caudatoputamen (CPu), is 
the main projecting site of the posterior CPu. Because of this result, we decided to infuse the 
retrograde adeno-associated virus with associated opsins into this region of the LGP (Figure 9). 
This allowed for the expression of the associated opsin (i.e. ChR2 or Jaws) to be primarily in the 
posterior CPu region of the auditory striatum.  
 
Figure 9. Illustrates the target infusion site of retrograde AAVs with the Paxinos and Watson 
stereotaxic coordinate atlas 2006 edition. The red dot is marked with the following coordinates (-
1.8mm AP, +3.9mm ML, -6.2mm DV, 00 tilt). Gaidica, M. (2019). Rat Brain Atlas. Retrieved 16 
December 2019, from http://labs.gaidi.ca/rat-brain-atlas/ 
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Figure 10. Expression of the retrograde AAV-hSyn-eGFP was observed in the reticular 
thalamus (RT), lateral globus pallidus (LGP) and the caudatoputamen (CPu). Triangles indicate 
cell body labeling in the Rt. Stars indicate labeling in the LGP-CPu border region. Arrows 
indicate cells labeled in the lateral aspect of the CPu. Scale bar is 1000 µm. 
 
Viral infusion into the LGP (-1.8mm AP, +3.9mm ML, -6.2mm DV) with retrograde Adeno-
associated viruses and their respected opsins, resulted in labeling of the reticular thalamus and 
lateral caudatoputamen border near the LGP (Figure 10). As depicted in Figure 11, this trend 
was observed in all retrograde viruses. However, the exact demarcation of the LGP-CPu border 
is uncertain. Though we are certain that LGP retroviral infusion resulted in CPu labeling not just 
around this border, but sparse amounts are shown throughout CPu (Figure 10).  
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Figure 11. Illustrates viral GFP expression mainly in the lateral globus pallidus (LGP), reticular 
thalamus (Rt) and minor expression in the caudatoputamen (CPu). Scale bar is 1000 µm 
 
43 
 
 
Figure 12. Magnified image of Striatal neurons of caudatoputamen transfected with AAV-hSyn-
Jaws-KGC-GFP-ER2. 
 
Figure 13. Example of excluded brain from c-Fos analysis due to no GFP expression in CPu. 
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3.4.2 Optogenetic stimulation of indirect pathway 
 
Figure 14. Illustration of Fiber optic stimulation paradigm. Including the region of stimulation 
CPu-GP microcircuit (-1.8 mm AP) and the region of expected activation primary auditory cortex 
(Au1, -4.30 mm AP). Illustration depicts the unilateral fiber optic stimulation with 630nm red light 
of the CPu-GP. 
 
 
 
 
45 
 
Figure 15. Expression of c-Fos in the posterior caudatoputamen of brain transfected with 
retrograde AAV-Syn-ChR2(H134R)-GFP in LGP. Scale bar 500µm.  
Figure 16. Expression of c-Fos in posterior caudatoputamen of all groups. White arrows depict 
c-fos expression. Scale bar 500µm.  
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Stimulation of caudatoputamen region near fiber optic placement (-1.8mm A/P, +4.4mm M/L, -
4.8mm D/V, 00 tilt) resulted in sparse c-Fos expression in rats transfected with AAV-GFP-only 
and AAV-Jaws (Figure 16). However, those transfected with AAV-ChR2 appeared to have more 
c-Fos labeling in striatum (Figure 15). The c-Fos expression in AAV-ChR2 brains was also more 
pronounced and easily recognized when compared to the AAV-GFP-only and AAV-Jaws. 
 
3.4.3 Images of Au1 and analysis of c-Fos 
 
Figure 17. Images depict the various levels of c-Fos expression in primary auditory cortex (Au1) 
of brains either expressing GFP-only, Jaws or ChR2, at approximately -4.3mm A/P in the 
Paxinos and Watson 2006 Stereotaxic atlas. Region of analysis for c-Fos was calculated to be 
roughly 4 mm2. Scale bar 500µm. 
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Figure 18. Depicts c-Fos cell counts of Au1 for brains containing GFP-only, ChR2, and Jaws 
when stimulated with appropriate wavelengths of light. *** p-value <0.001.  
 
Figure 19. Comparison of c-Fos cell counts of ipsilateral/contralateral Au1 regions respective to 
fiber optic placement. *** p-value <0.001. 
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 c-Fos cell counts  
Ipsilateral Au1 Contralateral Au1 
 Virus S1 S2 S3 Ave S1 S2 S3 Ave   
2R1(GFP) GFP 4 3 3 3.5 2 4 4 3.3   
2R2(GFP) GFP 8 15 28 17 9 7 10 8.7   
2R3(GFP) GFP 3 5 3 3.7 5 0 7 4.0   
R3 (GFP) GFP 13 15 14 14 15 7 9 10.3   
R4 (GFP) GFP 12 8 7 9 10 12 8 10   
R12(GFP) GFP 18 12 8 12.7 12 13 9 11.3   
2R7(CHR2) CHR2 23 25 24 24 21 11 31 21   
2R9(CHR2) CHR2 11 18 24 17.7 2 6 5 4.3   
2R10(CHR2) CHR2 11 5 12 9.3 14 20 11 15   
2R11(CHR2) CHR2 4 34 17 18.3 16 7 18 13.7   
2R12(CHR2) CHR2 0 4 2 2 1 5 2 2. 7   
R10(JAWS) JAWS 33 37 79 49.7 8 45 21 24.7   
R11(JAWS) JAWS 76 76 80 77.3 36 53 29 39.3   
2R5(JAWS) JAWS 118 105 99 107.3 13 20 17 16.7   
2R6 JAWS 47 45 47 46.3 16 7 9 10.7   
R1 JAWS 54 61 44 53 11 8 13 10.7   
          
Automated 
cell 
requirements 
Circularity 
measure 
Cell-size 
exclusion 
Area of 
analysis 
threshold    
 0.5-1.0 100-100k ~4 mm2 30-255    
Statistical 
summaries 
One-way ANOVA Tukey’s 
multiple comparison test 
Two-way ANOVA Sidak’s 
multiple comparisons test 
GFP vs. 
ChR2 
p-value = 0.9025  
GFP vs. 
Jaws 
p-value = 0.0001  
Jaws vs 
ChR2 
p-value = 0.0003  
Jaws 
ipsilateral vs 
Jaws 
contralateral 
 p-value = 0.0001 
     
Table 2. c-Fos cell counts and statistical analysis summaries. Excluded animals either did not 
meet the criteria for expression of GFP in caudatoputamen or were euthanized due to 
complications of surgery/infection.  
 
Stimulation of Jaws within striatal neurons of the indirect pathway resulted in the highest c-Fos 
cell counts in the primary auditory cortex (Au1) when compared to other groups (ChR2 and 
GFP). One-way ANOVA with Tukey’s multiple comparisons test (Table 2) showed that the only 
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observed significant difference between groups was that of Jaws vs. GFP (p-value = 0.0001) 
and Jaws vs. ChR2 (p-value = 0.0003). There were no significant differences between ChR2 vs. 
GFP (p-value = 0.9025). Comparing the c-Fos counts between ipsilateral to contralateral 
regions of Au1 respective to fiberoptic placement showed significant differences only in Jaws 
group (p-value = 0.0001). 
 
3.5 Discussion 
Traditionally the basal ganglia were solely the focus of motor behavior and the target of 
motor-related diseases (Galvin & Smith, 2010). However, recent studies have suggested several 
sensory processing pathways of the posterior striatum. These studies have shown that visual- 
and auditory-striatal subdivisions exist in the caudal regions of the dorsal striatum (Seger, 2013) 
of human and rodent brains. Even more recently, mouse studies have shown auditory sensory 
thalamus (Medial geniculate body of thalamus) and primary auditory cortex both project to an 
“auditory striatum” (Chen et al, 2019). Each of these projections to the posterior striatum carry 
unique auditory information as silencing either one of their projections impairs auditory frequency 
discrimination in specific frequency ranges (Chen et al, 2019). However, none of these studies, 
however, have examined the cortical-striato-pallido-thalamo-cortical pathway of auditory cortical 
activation mediated via the level of striatal-pallidal indirect pathway.  
Anatomical discrimination of the indirect pathway was accomplished in our tracer study, and the 
precise region of lateral globus pallidus (LGP; indirect pathway terminals) was determined. This 
region of the lateral globus pallidus was then targeted with a retrograde adeno-associated virus 
expressing the desired opsin (Jaws or ChR2) in the posterior striatum of rats (CPu, -1.8 mm A/P). 
We also showed previously that neurons expressing Jaws could be sufficiently activated with 3s 
pulse at 0.3Hz (parameter B). These results were then used to inactivate neurons of the indirect 
pathway with Jaws and also activate neurons of the direct pathway with ChR2. What we found 
was a significant c-Fos response in the primary auditory cortex (Au1, -4.3 mm A/P) with 630nm 
stimulation of Jaws with 3s pulse at 0.3Hz in the posterior striatum (-1.8mm AP, +3.9mm ML, -
4.8mm DV). There was no significant c-Fos response in the primary auditory cortex when 470nm 
stimulation of ChR2 was applied at 15ms pulse 10Hz in the posterior striatum. Ipsilateral 
expression of c-Fos in primary auditory cortex was significantly higher than contralateral 
expression only in animals stimulated with Jaws (p-value<0.001). We conclude that the 
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caudatoputamen to lateral globus pallidus neurons in rats contains auditory information and 
follows aspects of the canonical basal ganglia signaling.  
It is well known to researchers studying positive symptoms of schizophrenia how notoriously 
difficult it is to model these states. The most commonly used model for positive symptoms has 
been D2 receptor hyperactivity in the striatum (Canetta & Kallendonk, 2018). The aforementioned 
model has been used to depict correlations between enhanced striatal dopamine and the severity 
of positive symptoms. Our results illustrate a specified region of the posterior striatum in rodents 
that’s likely responsible for the positive symptoms experienced as a result of enhanced striatal 
dopamine. Therefore, our findings further specify and enhance future models aimed at explaining 
the pathophysiology of the positive symptoms of schizophrenia. 
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CHAPTER 4 
DISCUSSION 
In our experiments we have approached the cortio-striatal-pallidal-thalamo-cortical 
(CSPTC) loops, that have been more traditionally focused on motor related diseases, with the 
ideal of elucidating a mechanism for auditory cortical activation at the striatal level. Previous 
studies done within our lab have shown that dopamine infusions in this posterior region of the 
rodent striatum (CPu) are capable of eliciting activation of auditory cortex (Au1) (Parga, Zafar, 
Nikulina & Hammer, 2019). We know that this result is likely from dopamine’s effect on D2 
receptors, reducing cAMP via inhibition of adenylyl cyclase, causing disinhibition of thalamic 
nuclei via deactivation of external globus pallidus (Figure 1). The dopamine hypothesis has 
been a long standing, continuously evolving theory for explaining symptoms of psychosis 
(Howes & Kapur, 2009). Hyperdopaminergic states in the striatum have been correlated to 
symptoms of psychosis, such as auditory hallucinations (Howes & Kapur, 2009). This 
knowledge and prior experimenting led us to believe that there is a posterior region of the 
striatum capable of processing auditory information, and its ability to induce auditory 
hallucinations (activation) is contingent on indirect pathway activity at the striatal-pallidal level. 
This would provide a novel approach for understanding the role of striatal pathophysiology in 
auditory hallucinations. 
Though we knew that dopamine infusions into the posterior caudatoputamen (-1.8mm A/P, 
+4.4mm M/L, -6.0mm D/V, 00 tilt) was able to activate the auditory cortex, and that this was 
likely through D2 receptor activation on indirect neurons, we were unsure of where in the lateral 
globus pallidus that these striatal neurons projected to. Utilizing an anterograde adeno-
associated virus, infusing at the same point of the dopamine infusions, we found that terminals 
mainly projected to the LGP at the same rostral-caudal level as viral infusion site (-1.8mm A/P). 
This result allowed us to target the same striatal neurons with virally expressed opsins (Jaws 
and ChR2). However, we knew from previous studies that ChR2 is effective at stimulating 
neurons with 15ms pulses at 10Hz, but we were unsure of what parameters would be effective 
with Jaws. Boyden’s lab did a thorough analysis on the Jaws opsin and found that continuous 
parameters were best when inactivating neurons with Jaws (Chuong et al., 2014). Therefore, we 
developed two pseudo-continuous parameters (8s pulse 0.1 Hz and 3s pulse 0.3Hz) that would 
work with our experiment and ran a preliminary study to test them. We transfected rats with 
retrograde AAV-Jaws-GFP into a motor region of the LGP-CPu microcircuit (-1.0mm A/P, 
+2.9mm M/L, -6.0mm D/V, 00). We hypothesized that inhibiting this circuit would activate motor 
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cortices and we would compare the amount of c-Fos expression as a level of the parameter’s 
effectiveness. There was no significant difference (n=1, p-value=0.1314) in the amount of c-Fos 
expression. In spite of this, qualitative analysis of the c-Fos expression showed better results for 
3s pulse at 0.3Hz when activating the motor cortices. Therefore, we decided to use this 
parameter for our future studies involving Jaws. 
Utilizing the LGP coordinates (-1.8mm A/P, +3.9mm M/L, -6.2mm D/V, 00 tilt) we virally infused 
retroactive adeno-associated viruses with Jaws into the LGP and retrogradely expressed Jaws 
into striatal indirect neurons. Stimulation of these neurons with 630nm red-light with 3s pulse at 
0.3Hz produced c-Fos expression in the primary auditory cortex that was significantly greater 
than those of retrograde AAV-hSyn-GFP brains (n=6, p-value =0.0001) and also brains 
stimulated with 470nm blue-light that were transfected with retrograde AAV-ChR2(H134r)-GFP 
(n=5, p-value=0.0003). We also compared the ipsilateral and contralateral primary auditory 
cortices with respect to fiber optic probe and found that Jaws inactivation of striatal-pallidal 
neurons resulted in significantly greater amounts of ipsilateral expression of c-Fos (n=5, p-
value=0.0001). This result is consistent with experiments that showed activation of unilateral 
auditory cortex in mice with picrotoxin infusions only resulted in ipsilateral Fos expression in 
caudal striatum (Arnauld et al., 1996). Therefore, our results complement the notion of a 
topographical organization of cortico-striatal-pallidal-thalamo-cortical connections that process 
auditory information.  
 
4.1 Conclusion 
The results from our experiments are critical findings, as recent literature has yet to 
associate the functional significance of D2 receptor expressing indirect pathway striatal neurons 
of posterior striatum with the perception of sound. I believe our results show the significance of 
a striatal-pallidal microcircuit that can be further established to model auditory hallucinations 
experienced by sufferers with schizophrenia. These results provide for an understanding of the 
role of striatal pathophysiology in regard to auditory hallucinations. This is not only a result that 
can further refine our models of schizophrenia for research but also potentially improve targeted 
therapeutics for those suffering from the symptoms of psychosis.  
 
 
53 
 
4.2 Future studies 
From the results of our experiments we know that a striatal-pallidal indirect pathway 
microcircuit capable of activating the auditory cortex exists. However, we do not know 
specifically how this pathway contributes to the experience of the positive symptoms of 
schizophrenia. At this point, we are left to speculate whether it is the pathway responsible for 
internally generated sound processes or something else. I propose future experiments which 
aim towards establishing this pathway’s function in regard to sensorimotor gating. We know 
from cross-sectional studies that Prepulse inhibition (PPI) is an effective biomarker for acute 
and chronic sufferers of schizophrenia (Mena et al., 2016). It would be interesting to see how 
this striatal-pallidal indirect pathway would affect Prepulse inhibition in rats. I speculate that 
inhibition of this microcircuit would result in reduced PPI in rats, analogous to reduced PPI seen 
in those suffering from schizophrenia.   
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